Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Genomics BioSci & Tech. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	121.93	172.58	253.03	317	107.5	476.94
Short-Term Investments	55.3	65	-	-	-	98
Cash & Short-Term Investments	177.23	237.58	253.03	317	107.5	574.94
Cash Growth	-32.21%	-6.11%	-20.18%	194.90%	-81.30%	36.20%
Accounts Receivable	165.09	138.86	116.1	100.02	81.75	79.18
Other Receivables	0.25	0.39	0.74	0.01	1.44	0.58
Receivables	165.34	139.25	116.84	100.02	83.2	79.77
Inventory	206.92	185.49	61.51	54.8	20.99	24
Prepaid Expenses	13.21	18.09	16.85	8.83	21.92	26.88
Other Current Assets	22.79	34.77	23.58	17.45	18.23	12.38
Total Current Assets	585.49	615.19	471.82	498.1	251.83	717.96
Property, Plant & Equipment	672.81	648.43	498.69	373.37	311.02	306
Long-Term Investments	75.72	82	153.98	237.96	285.83	110.32
Other Intangible Assets	5.25	5.77	1.73	0.86	1.16	3.92
Long-Term Accounts Receivable	0.32	0.64	-	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	0.07	0.1
Other Long-Term Assets	21.89	8.33	7.63	9.44	3.27	16.96
Total Assets	1,361	1,360	1,134	1,120	853.18	1,155
Accounts Payable	72.79	97.4	29.73	40.47	27.31	31.41
Accrued Expenses	33.52	35.4	28.7	34.5	27.54	71.93
Short-Term Debt	212.35	128.96	50	50	-	50
Current Portion of Long-Term Debt	48.3	35.41	4.86	12.4	3.9	3.87
Current Portion of Leases	5.91	6.43	6.51	4.75	3.39	5.23
Current Income Taxes Payable	-	-	-	0.58	-	-
Current Unearned Revenue	46.62	43.69	12.72	20	18.89	11.99
Other Current Liabilities	14.85	35.48	13.57	6.21	13.57	14.58
Total Current Liabilities	434.32	382.77	146.09	168.91	94.59	189.02
Long-Term Debt	318.09	328.89	214.01	153.35	75.67	44.22
Long-Term Leases	7.83	7.98	8.24	8.34	3.58	14.32
Other Long-Term Liabilities	0.01	-	-	-	-	-
Total Liabilities	760.25	719.64	368.33	330.6	173.84	247.56
Common Stock	724.48	724.48	724.48	630.28	578.92	578.92
Additional Paid-In Capital	-	30.15	131.53	58.91	43.76	38.88
Retained Earnings	-198.03	-204.06	-88.24	101.85	36.07	16.09
Comprehensive Income & Other	-2.75	-1.84	-2.25	-1.91	20.59	38.29
Total Common Equity	523.71	548.73	765.51	789.13	679.34	672.18
Minority Interest	77.52	91.99	-	-	-	235.52
Shareholders' Equity	601.23	640.73	765.51	789.13	679.34	907.7
Total Liabilities & Equity	1,361	1,360	1,134	1,120	853.18	1,155
Total Debt	592.47	507.67	283.61	228.84	86.53	117.64
Net Cash (Debt)	-415.24	-270.08	-30.58	88.17	20.96	457.3
Net Cash Growth	-	-	-	320.57%	-95.42%	24.15%
Net Cash Per Share	-5.73	-3.73	-0.43	1.39	0.35	7.58
Filing Date Shares Outstanding	72.45	72.45	72.45	64.29	60.23	60.23
Total Common Shares Outstanding	72.45	72.45	72.45	64.29	60.23	60.23
Working Capital	151.17	232.42	325.73	329.19	157.24	528.94
Book Value Per Share	7.23	7.57	10.57	12.27	11.28	11.16
Tangible Book Value	518.47	542.96	763.78	788.27	678.18	668.26
Tangible Book Value Per Share	7.16	7.49	10.54	12.26	11.26	11.10
Land	206.74	206.74	139.79	104.76	104.76	86.67
Buildings	266.97	256.36	211.33	144.63	134.61	101.25
Machinery	256.12	234.39	231.91	142.81	150.45	234.52
Construction In Progress	61.04	52.59	0.23	79.45	26.25	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.